 |
|
Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular DiseaseA Randomized Trial
Christine M. Albert, MD, MPH;
Nancy R. Cook, ScD;
J. Michael Gaziano, MD, MPH;
Elaine Zaharris, BA;
Jean MacFadyen, BA;
Eleanor Danielson, MIA;
Julie E. Buring, ScD;
JoAnn E. Manson, MD, DrPH
JAMA. 2008;299(17):2027-2036.
Context Recent randomized trials among patients with preexisting cardiovascular disease (CVD) have failed to support benefits of B-vitamin supplementation on cardiovascular risk. Observational data suggest benefits may be greater among women, yet women have been underrepresented in published randomized trials.
Objective To test whether a combination of folic acid, vitamin B6, and vitamin B12 lowers risk of CVD among high-risk women with and without CVD.
Design, Setting, and Participants Within an ongoing randomized trial of antioxidant vitamins, 5442 women who were US health professionals aged 42 years or older, with either a history of CVD or 3 or more coronary risk factors, were enrolled in a randomized, double-blind, placebo-controlled trial to receive a combination pill containing folic acid, vitamin B6, and vitamin B12 or a matching placebo, and were treated for 7.3 years from April 1998 through July 2005.
Intervention Daily intake of a combination pill of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12.
Main Outcome Measures A composite outcome of myocardial infarction, stroke, coronary revascularization, or CVD mortality.
Results Compared with placebo, a total of 796 women experienced a confirmed CVD event (406 in the active group and 390 in the placebo group). Patients receiving active vitamin treatment had similar risk for the composite CVD primary end point (226.9/10 000 person-years vs 219.2/10 000 person-years for the active vs placebo group; relative risk [RR], 1.03; 95% confidence interval [CI], 0.90-1.19; P = .65), as well as for the secondary outcomes including myocardial infarction (34.5/10 000 person-years vs 39.5/10 000 person-years; RR, 0.87; 95% CI, 0.63-1.22; P = .42), stroke (41.9/10 000 person-years vs 36.8/10 000 person-years; RR, 1.14; 95% CI, 0.82-1.57; P = .44), and CVD mortality (50.3/10 000 person-years vs 49.6/10 000 person-years; RR, 1.01; 95% CI, 0.76-1.35; P = .93). In a blood substudy, geometric mean plasma homocysteine level was decreased by 18.5% (95% CI, 12.5%-24.1%; P < .001) in the active group (n = 150) over that observed in the placebo group (n = 150), for a difference of 2.27 µmol/L (95% CI, 1.54-2.96 µmol/L).
Conclusion After 7.3 years of treatment and follow-up, a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high-risk women, despite significant homocysteine lowering.
Trial Registration clinicaltrials.gov Identifier: NCT00000541
Author Affiliations: Divisions of Preventive Medicine (Drs Albert, Cook, Gaziano, Buring, and Manson and Mss Zaharris, MacFadyen, and Danielson), Cardiovascular Medicine (Drs Albert and Gaziano), and Aging (Drs Gaziano and Buring), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Veterans Affairs Boston Healthcare System, Boston, Massachusetts (Dr Gaziano); Department of Ambulatory Care and Prevention, Harvard Medical School (Dr Buring); and Department of Epidemiology, Harvard School of Public Health, Boston (Drs Cook, Buring, and Manson).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
George Ntaios, Christos Savopoulos, and Dimitrios Karamitsos
JAMA. 2008;300(12):1409.
EXTRACT
| FULL TEXT
Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
Ainur Akilzhanova, Noboru Takamura, and Shunichi Yamashita
JAMA. 2008;300(12):1409-1410.
EXTRACT
| FULL TEXT
Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
Weekitt Kittisupamongkol
JAMA. 2008;300(12):1410.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention—Wrong Again?
Eva Lonn
JAMA. 2008;299(17):2086-2087.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Novel markers of peripheral arterial disease
Khawaja and Kullo
Vasc Med 2009;14:381-392.
ABSTRACT
The Role of Micronutrients in Managing Diabetes
Chehade et al.
Diabetes Spectr. 2009;22:214-218.
ABSTRACT
| FULL TEXT
Lack of Phosphatidylethanolamine N-Methyltransferase Alters Plasma VLDL Phospholipids and Attenuates Atherosclerosis in Mice
Zhao et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1349-1355.
ABSTRACT
| FULL TEXT
Plasma Vitamin B6 and Risk of Myocardial Infarction in Women
Page et al.
Circulation 2009;120:649-655.
ABSTRACT
| FULL TEXT
Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women: A Randomized, Controlled Trial
Song et al.
Diabetes 2009;58:1921-1928.
ABSTRACT
| FULL TEXT
Multivitamin Supplements, Ageing, and Loss of Vision: Seeing Through the Shadows
Phillips and Higginbotham
Arch Intern Med 2009;169:1180-1182.
FULL TEXT
Response to Letter by Obeid and Herrmann
Saposnik et al.
Stroke 2009;40:e517-e517.
FULL TEXT
Update of secondary stroke prevention
Diener and Weimar
Nephrol Dial Transplant 2009;24:1718-1724.
FULL TEXT
Micronutrients and Older Adults
Marian and Sacks
Nutr Clin Pract 2009;24:179-195.
ABSTRACT
| FULL TEXT
Nutrient supplements and cardiovascular disease: a heartbreaking story
Lichtenstein
J. Lipid Res. 2009;50:S429-S433.
ABSTRACT
| FULL TEXT
Mouse models of cystathionine {beta}-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia
Gupta et al.
FASEB J. 2009;23:883-893.
ABSTRACT
| FULL TEXT
Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women: The Women's Antioxidant and Folic Acid Cardiovascular Study
Christen et al.
Arch Intern Med 2009;169:335-341.
ABSTRACT
| FULL TEXT
Vitamin Supplements and Cancer Prevention: Where Do Randomized Controlled Trials Stand?
Albanes
JNCI J Natl Cancer Inst 2009;101:2-4.
FULL TEXT
Invited Commentary: Preventing Neural Tube Defects and More via Food Fortification?
Mills and Carter
Am J Epidemiol 2009;169:18-21.
ABSTRACT
| FULL TEXT
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
Kang et al.
Am. J. Clin. Nutr. 2008;88:1602-1610.
ABSTRACT
| FULL TEXT
Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12 on Cancer Risk in Women: A Randomized Trial
Zhang et al.
JAMA 2008;300:2012-2021.
ABSTRACT
| FULL TEXT
Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
Ntaios et al.
JAMA 2008;300:1409-1409.
FULL TEXT
Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
Kittisupamongkol
JAMA 2008;300:1410-1410.
FULL TEXT
Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
Akilzhanova et al.
JAMA 2008;300:1409-1410.
FULL TEXT
Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial
Ebbing et al.
JAMA 2008;300:795-804.
ABSTRACT
| FULL TEXT
Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?
Van Wagoner
Europace 2008;10:899-900.
FULL TEXT
The Myth of Heart-Protective B Vitamins
JWatch Women's Health 2008;2008:3-3.
FULL TEXT
All you need to read in the other general journals
BMJ 2008;336:1096-1097.
FULL TEXT
Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention--Wrong Again?
Lonn
JAMA 2008;299:2086-2087.
FULL TEXT
Folic Acid, B Vitamins, and Heart Disease in Women
JWatch General 2008;2008:1-1.
FULL TEXT
|
